Fifty-six patients with clinical threatened abortion were evaluated by sonography. In six patients, fetal cardiac activity was absent at or beyond 9 weeks of gestation, and fetal death was confirmed in all six cases. In the other 50 patients, fetal cardiac activity was present at or beyond 9 weeks of gestation. In 10 (20%) of these 50 patients, subchorionic bleeding was present in various degrees, appearing sonographically as an extrachorionic crescentic anechoic or complex collection. The final outcome in the 50 patients with fetal cardiac activity was as follows: In the absence of subchorionic bleeding, 100% of the pregnancies progressed to term; in the presence of subchorionic bleeding the positive outcome was reduced to 80%. In addition to signs of fetal life on sonography, subchorionic bleeding is an important factor affecting the outcome of gestations in patients with clinical threatened abortion.
The sonographic and computed tomographic findings in 3 cases of diffuse xanthogranulomatous pyelonephritis are presented along with correlation with the pathological specimens. The combination of the findings in sonography and computed tomography in this condition enables one to make an accurate preoperative diagnosis. Calyces containing pus and/or xanthomatous tissue produced low-level echoes simulating preservation or thickening of the renal parenchyma on sonography. On CT the central low attenuation areas either gave negative values representing abundant xanthomatous tissue seen on gross pathology, or measured in the water density range representing a combination of pus and less abundant xanthomatous tissue.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.